Erschienen in:
02.03.2017 | Editorial
Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system
atrophy? And other updates on recent autonomic research
verfasst von:
Srikanth Muppidi, Mitchell G. Miglis
Erschienen in:
Clinical Autonomic Research
|
Ausgabe 2/2017
Einloggen, um Zugang zu erhalten
Excerpt
Pure autonomic failure (PAF) is a disorder of α-synuclein deposition that results in neurogenic orthostatic hypotension (OH) and other features of autonomic failure, without signs of central nervous system (CNS) involvement. If patients are followed for a sufficient period, some may eventually develop Parkinson disease (PD), multiple system atrophy (MSA), or dementia with Lewy bodies (DLB). Determining which patients will go on to convert to a CNS synucleinopathy and which will remain as PAF has been, so far, a prognostic dilemma for medical providers. Is PAF purely peripheral and restricted to the autonomic nerves, or does it presage a more widespread CNS disorder? …